InsidersTradesSigma
Explore the full management transaction log of Pharmanutra Pharmanutra - PHN - Orientamenti del CDA Agli Azionisti Sulla Futura Dimensione e Composizione del Nuovo CDA - Nomina Dell’investor Relator, a listed equity based in Italy. Shares are listed on IT IT, under the supervision of Consob. Operating in the Healthcare sector, Pharmanutra Pharmanutra - PHN - Orientamenti del CDA Agli Azionisti Sulla Futura Dimensione e Composizione del Nuovo CDA - Nomina Dell’investor Relator has logged 1 insider filings. Market capitalisation: €861.8m. The latest transaction was reported on 23 February 2026 — Other. Among the most active insiders: Unknown. The full history is accessible without an account.
FY ended December 2025 · cache
0 of 0 declarations